Jobs filters
CLINICAL FACULTY - ANESTHESIOLOGIST - 10020845
Duarte, CATENURE-TRACK ASSISTANT, ASSOCIATE OR FULL PROFESSOR - DIABETES IMMUNOLOGY - 10021527
Duarte, CAPHYSICIAN - FELLOWSHIP TRAINED RADIOLOGIST - 10021404
Irvine, CARECONSTRUCTIVE GENITOURINARY SURGEON/GENERAL UROLOGIST (IRVINE, CA) - 10021033
Irvine, CAPOSTDOCTORAL FELLOW - BIOMEDICAL ENGINEERING - 10021241
Duarte, CACLINICAL SOCIAL WORKER II - 10019506
Duarte, CAPOSTDOCTORAL FELLOW - CANCER IMMUNOTHERAPY AND MACROPHAGE BIOLOGY - 10020577
Duarte, CADERMATOLOGIST - PHYSICIAN - 10018186
Irvine, CAPOSTDOCTORAL FELLOW - CELLULAR GENE THERAPY AND STEM CELL RESEARCH - 10020541
Duarte, CAASSISTANT RESEARCH PROFESSOR - PRECISION ONCOLOGY OF GASTROINTESTINAL CANCERS - 10020708
Monrovia, CAPOSTDOCTORAL FELLOW - COMPUTATIONAL BIOLOGY, BIOSTATISTICS AND BIOINFORMATICS - 10020705
Monrovia, CASTAFF SCIENTIST - PRECISION ONCOLOGY OF GASTROINTESTINAL CANCERS - 10020709
Monrovia, CA
POSTDOCTORAL FELLOW - CANCER IMMUNOTHERAPY AND MACROPHAGE BIOLOGY - 10020577
Duarte, CACity of Hope is an independent biomedical research and treatment center for cancer, diabetes and other life-threatening diseases.
Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope’s translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a wholly owned subsidiary, was launched in 2019 and is dedicated to serving employers and their health care partners by providing access to City of Hope’s exceptional cancer expertise.
A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked among the nation’s “Best Hospitals” in cancer by U.S. News & World Report and received Magnet Recognition from the American Nurses Credentialing Center. Its main campus is located near Los Angeles, with additional locations throughout Southern California and in Arizona.
Join the forefront of groundbreaking research at the Beckman Research Institute of City of Hope, where we're changing lives and making a real difference in the fight against cancer, diabetes, and other life-threatening illnesses. Our dedicated and compassionate faculty and staff are driven by a common mission: Contribute to innovative approaches in predicting, preventing, and curing diseases, shaping the future of medicine through cutting-edge research.
Dr. Mingye Feng’s laboratory at the Beckman Research Institute of City of Hope is looking for a talented and highly motivated Postdoctoral Fellow. Dr. Feng is an awardee of the V Scholar Award from the V Foundation for Cancer Research, the Damon Runyon – Dale F. Frey Award for Breakthrough Scientists from the Damon Runyon Cancer Research Foundation, the K99/R00 Pathway to Independence Award from NIH, and NIH R01 grants. His laboratory employs cutting-edge techniques to understand mechanisms of macrophages in cancer immunosurveillance, identify immune checkpoints and ligands on various hematopoietic malignant and solider tumor cells with high-throughput screening and protein engineering approaches developed in the lab, and develop novel cancer immunotherapies targeting metastatic cancer cells. Cancer immunotherapy is one of the most important breakthroughs in the development of cancer treatment approaches. As one of the largest populations of immune cells in human body and the major components of primary tumors and the metastatic sites, macrophages are key effectors mediating tumor immunosurveillance and thus macrophage-based cancer immunotherapy is one of the most promising fields in cancer immunology and the next generation of cancer immunotherapy. For more information about Dr. Mingye Feng’s lab, please visit here.
As a successful candidate, you will:
- Utilize a combination of in vitro cell biological, molecular biological and immunological assays, large-scale high-throughput screening approaches (CIRSPR screen, drug screen, etc.) and in vivo models to study interactions between cancer cells and macrophages and develop strategies to enable macrophage-mediated cancer immunotherapies.
Your qualifications should include:
- A Ph.D. degree in cancer biology, immunology or a related discipline.
- Experience in cell biology, cancer biology and/or immunology along with excellent verbal and written skills and integral working ethics.
City of Hope is an equal opportunity employer. To learn more about our commitment to diversity, equity and inclusion, pleaseclick here.
#PD